½ÃÀ庸°í¼­
»óǰÄÚµå
1528047

¼¼°èÀÇ ½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀå

Cardiovascular Disease Monitoring and Diagnostic Devices

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 283 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ÀÇ ½ÃÀåÀº 2030³â±îÁö 36¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 27¾ï ´Þ·¯·Î ÃßÁ¤µÈ ½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.6%·Î ¼ºÀåÇØ 2030³â¿¡´Â 36¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ECG ½Ã½ºÅÛÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.0%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ȦÅÍ ¸ð´ÏÅÍ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 1,730¸¸ ´Þ·¯, Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ ½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀåÀº 2023³â 7¾ï 1,730¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» 7.8%·Î 2030³â±îÁö 7¾ï 8,340¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 1.3%¿Í 5.2%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 2.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡´Â ȯÀÚÀÇ ¿¹Èĸ¦ ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

½ÉÇ÷°üÁúȯ(CVD)Àº ¿©ÀüÈ÷ ¼¼°èÀÇ ÁÖ¿ä »çÀÎÀ̱⠶§¹®¿¡ ½ÉÀå °ü·Ã Áúº´À» ¿¹¹æÇÏ°í °ü¸®ÇϱâÀ§ÇÑ Áø´Ü ¹× ¸ð´ÏÅ͸µ ±â¼úÀÇ Áøº¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ÃֽнÉÇ÷°ü ¸ð´ÏÅ͸µ ¹× Áø´Ü Àåºñ´Â ±âº» ûÁø±âºÎÅÍ º¹ÀâÇÑ ¿µ»ó Áø´Ü ¹× ¿þ¾î·¯ºí ±â¼ú¿¡ À̸£±â±îÁö ´Ù¾çÇÑ µµ±¸¸¦ Á¦°øÇÕ´Ï´Ù. ½ÉÀüµµ(ECG), ½É ÃÊÀ½ÆÄ, ½ÉÀå ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT) ½ºÄµÀº ½ÉÀå ÀÌ»ó, ºÎÁ¤¸Æ, Æó»öÀ» °ËÃâÇÏ°í Æò°¡Çϱâ À§ÇÑ Ç¥ÁØ °Ë»çÀÔ´Ï´Ù. ¶ÇÇÑ ¿þ¾î·¯ºí ±â¼úÀÇ Çõ½ÅÀ¸·Î ½É¹Ú¼ö, Ç÷¾Ð, ±âŸ ¹ÙÀÌÅ» »çÀÎÀ» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â ÀåÄ¡µµ °³¹ßµÇ¾î »ý¸íÀ» À§ÇùÇϱâ Àü¿¡ ÀáÀçÀûÀÎ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â CVD¸¦ Á¶±â¿¡ Áø´ÜÇϰí Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÅëÇØ ȯÀÚ °ü¸®¸¦ Å©°Ô °­È­ÇÏ°í ±Ã±ØÀûÀ¸·Î ȯÀÚ °á°ú¸¦ °³¼±Çϸç ÀÀ±Þ °³ÀÔÀÇ Çʿ伺À» ÁÙÀÌ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÉÇ÷°ü Áø´ÜÀÇ Àå·¡¸¦ Çü¼ºÇÏ´Â ±â¼ú Çõ½ÅÀ̶õ?

½ÉÇ÷°ü Áø´Ü ºÐ¾ß´Â ÀÇ·á ±â¼ú°ú µðÁöÅÐ °Ç°­ÀÇ ºñ¾àÀû Áøº¸·Î ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. °¡Àå Å« ¹ßÀü Áß Çϳª´Â ½ÉÇ÷°ü°èÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ¸ð¹ÙÀÏ Çコ ¿ëµµ°ú ¿þ¾î·¯ºí ¼¾¼­ ºÐ¾ßÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ½É¹Ú¼ö º¯µ¿, »ê¼Ò ¼öÁØ, ½ÉÀüµµ µ¥ÀÌÅ͸¦ ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç ½ÉÀå ±â´É¿¡ ´ëÇÑ ÀλçÀÌÆ®À» Á¦°øÇϸç ÀáÀçÀûÀÎ °Ç°­ ¹®Á¦¸¦ »ç¿ëÀÚ ¹× °Ç°­ °ü¸® Á¦°ø¾÷ü¿¡°Ô °æ°íÇÕ´Ï´Ù. ÀΰøÁö´É(AI)Àº ¶Ç ´Ù¸¥ ÇÁ·ÐƼ¾îÀ̸ç, ÇöÀç´Â ¿µ»ó Áø´ÜÀ̳ª ¸ð´ÏÅ͸µ ±â±â¿¡¼­ ¾òÀº ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ°í ½ÉÀ庴À» º¸´Ù Á¤È®ÇÏ°Ô ¿¹ÃøÇϰųª °³ÀÔÃ¥À» Á¦¾ÈÇÏ´Â ¾Ë°í¸®Áò °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ 3D ½É ÃÊÀ½ÆÄ °Ë»ç ¹× °í±Þ MRI ±â¼ú°ú °°Àº À̹Ì¡ ±â¼úÀÇ ¹ßÀüÀ¸·Î ½ÉÀåÀÇ º¸´Ù ¼±¸íÇÏ°í »ó¼¼ÇÑ À̹ÌÁö¸¦ ¾òÀ» ¼ö ÀÖÀ¸¸ç ħ½ÀÀû ÀÎ Ä¡·á¸¦ ÇÊ¿ä·ÎÇÏÁö ¾Ê°íº¸´Ù Á¤È®ÇÑ Áø´ÜÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¸°Ô µÇ¾ú½À´Ï´Ù.

±ÔÁ¦ ¹× ÇコÄɾî Á¤Ã¥Àº ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ÀåºñÀÇ Àü°³¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú ÇコÄɾî Á¤Ã¥Àº ½ÉÇ÷°ü ¸ð´ÏÅ͸µ ¹× Áø´Ü ±â±âÀÇ µµÀÔ°ú ½Ç½Ã¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú À¯·´¾àû(EMA) µîÀÇ ±ÔÁ¦±â°üÀº ÀÇ·á±â±âÀÇ ½ÂÀο¡ ¾ö°ÝÇÑ ±âÁØÀ» ¸¶·ÃÇØ ¾ÈÀü¼º°ú À¯È¿¼ºÀÇ ±âÁØÀ» ÃæÁ·Çϰí ÀÖ´Â °ÍÀ» È®ÀÎÇÏ°í ³ª¼­ ÆÇ¸Å ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â »õ·Î¿î ÀÇ·á±â±â°¡ ½ÃÀå¿¡ Ãâ½ÃµÇ´Â ¼Óµµ¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç »ç¿ëÀ» µÑ·¯½Ñ ÀÓ»ó °üÇà¿¡µµ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶Ç ´Ù¸¥ Ãø¸éÀº »óȯ ¹× º¸Çè Àû¿ë¿¡ ´ëÇÑ °Ç°­ °ü¸® Á¤Ã¥ÀÌ ÀÌ·¯ÇÑ ±â¼ú¿¡ ´ëÇÑ È¯ÀÚÀÇ Á¢±Ù¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù´Â °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, º¸ÇèÀÌ Àû¿ëµÇ´Â Àåºñ´Â ³Î¸® »ç¿ëµÉ °¡´É¼ºÀÌ ³ôÀ¸¸ç ½ÉÀ庴ÀÇ Á¶±â Áø´Ü°ú ´õ ³ªÀº °ü¸®¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ Àåºñ Á¦Á¶¾÷ü, ÀÇ·á Àü¹®°¡ ¹× ±ÔÁ¦±â°ü °£ÀÇ Áö¼ÓÀûÀÎ »óÈ£ÀÛ¿ëÀº ±â¼ú Çõ½Å°ú ȯÀÚÀÇ ¾ÈÀü°ú Á¢±Ù °£ÀÇ ±ÕÇüÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº Àα¸ °í·ÉÈ­ ¹× ºñ¸¸, ´ç´¢º´ ¹× ±âŸ À§Çè ¿äÀÎ Áõ°¡·Î ÀÎÇÑ ¼¼°è ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ¶ÇÇÑ º¸´Ù Á¤È®Çϰí ħ½À¼ºÀÌ ³·°í »ç¿ëÇϱ⠽¬¿î ¸ð´ÏÅ͸µ ¿É¼ÇÀ» Á¦°øÇÏ´Â ±â¼úÀÇ Áøº¸´Â ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ Çâ»ó½Ã۰í ÀÓ»ó ȯ°æ°ú °¡Á¤ ȯ°æ ¸ðµÎ¿¡¼­ »ç¿ëÇϱ⠽±±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¼ºÀåÀ» ÀÚ±ØÇÕ´Ï´Ù. ¶ÇÇÑ, Áø´Ü ÀýÂ÷¿¡¼­ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ Áõ°¡´Â º¸´Ù Á¤È®ÇÏ°í ¸ÂÃã Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç °í±Þ Áø´Ü ÀåºñÀÇ Ãß°¡ äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ¼­ºñ½º È®´ë, ÀÏ¹Ý ÁÖ¹ÎÀÇ °Ç°­ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ ¼ö¿ä°¡ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ °æÁ¦°³Ã´°ú ÇコÄɾî ÁöÃâ Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©ÇØ, Á¦Á¶¾÷ü¿Í ÀÇ·á Á¦°øÀÚ ½Ö¹æ¿¡°Ô »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ½ÉÇ÷°üÁúȯ ¸ð´ÏÅ͸µ ¹× Áø´Ü ÀåÄ¡ ½ÃÀåÀº °ßÁ¶ÇÑ ¼ºÀå±Ëµµ¸¦ ¹¦»çÇϰí ÀÖÀ¸¸ç, º¸´Ù ±¤¹üÀ§ÇÑ °Ç°­°ü¸® ¸ñÇ¥¿¡ ºÎÇÕÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 62°Ç)

  • BioTelemetry Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • GE Healthcare UK Ltd.
  • Koninklijke Philips NV
  • Medtronic Plc.
  • Mortara Instrument Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Schiller AG
  • Spacelabs Healthcare Inc.
  • St. Jude Medical Inc.
  • Welch Allyn

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

BJH

Global Cardiovascular Disease Monitoring and Diagnostic Devices Market to Reach US$3.6 Billion by 2030

The global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.7 Billion in the year 2023, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. ECG Systems, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Holter Monitors segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$717.3 Million While China is Forecast to Grow at 7.8% CAGR

The Cardiovascular Disease Monitoring and Diagnostic Devices market in the U.S. is estimated at US$717.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$783.4 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Cardiovascular Disease Monitoring and Diagnostic Devices Market - Key Trends and Drivers Summarized

How Are Cardiovascular Disease Monitoring and Diagnostic Devices Enhancing Patient Outcomes?

Cardiovascular disease (CVD) remains a leading cause of death globally, necessitating advancements in diagnostic and monitoring technologies to prevent and manage heart-related illnesses. Modern cardiovascular monitoring and diagnostic devices include a range of tools from basic stethoscopes to complex imaging and wearable technology. Electrocardiograms (ECGs), echocardiograms, and cardiac computerized tomography (CT) scans are standard in detecting and assessing heart abnormalities, arrhythmias, and blockages. Innovations in wearable technology have also led to the development of devices that continuously monitor heart rate, blood pressure, and other vital signs, allowing for early detection of potential issues before they become life-threatening. These devices are crucial for diagnosing CVD at an early stage and significantly enhancing patient management through continuous monitoring, ultimately improving patient outcomes and reducing the need for emergency interventions.

What Technological Innovations Are Shaping the Future of Cardiovascular Diagnostics?

The field of cardiovascular diagnostics is rapidly evolving, driven by breakthroughs in medical technology and digital health. One of the most significant advancements is in the area of mobile health applications and wearable sensors that offer real-time monitoring of cardiovascular health. These devices can track heart rate variability, oxygen levels, and electrocardiographic data, providing insights into heart function and alerting users and healthcare providers to potential health issues. Artificial intelligence (AI) is another frontier, with algorithms now capable of analyzing vast amounts of data from imaging and monitoring devices to predict heart disease more accurately and even suggest interventions. Furthermore, advancements in imaging technology, such as 3D echocardiography and advanced MRI techniques, provide clearer, more detailed views of the heart, allowing for more precise diagnoses without the need for invasive procedures.

How Do Regulatory and Healthcare Policies Impact the Deployment of Cardiovascular Monitoring Devices?

Regulatory frameworks and healthcare policies play pivotal roles in the adoption and implementation of cardiovascular monitoring and diagnostic devices. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) set stringent standards for the approval of medical devices, ensuring they meet safety and efficacy criteria before they can be marketed. These regulations affect the speed at which new devices reach the market and influence the clinical practices surrounding their use. On another front, healthcare policies regarding reimbursement and coverage significantly impact patient access to these technologies. For instance, devices that are covered by insurance are more likely to be used widely, which can drive earlier diagnostics and better management of heart disease. Therefore, continuous dialogue between device manufacturers, healthcare professionals, and regulatory bodies is essential to balance innovation with patient safety and access.

What Drives the Growth in the Cardiovascular Disease Monitoring and Diagnostic Devices Market?

The growth in the cardiovascular disease monitoring and diagnostic devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally due to aging populations and increasing rates of obesity, diabetes, and other risk factors. Technological advancements that offer more accurate, less invasive, and user-friendly monitoring options also stimulate this growth, as they improve patient compliance and ease of use in both clinical and home settings. Additionally, the increasing integration of AI and machine learning in diagnostic procedures helps in providing more precise and personalized treatment options, encouraging further adoption of advanced diagnostic devices. The expansion of healthcare infrastructure and services worldwide, along with growing health awareness among the general population, further fuels the demand for these devices. Economic development and increased healthcare expenditure in emerging markets also contribute to the market expansion, providing new opportunities for manufacturers and healthcare providers alike. These factors collectively ensure a robust growth trajectory for the cardiovascular disease monitoring and diagnostic devices market, aligning with broader health management goals.

Select Competitors (Total 62 Featured) -

  • BioTelemetry Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • GE Healthcare UK Ltd.
  • Koninklijke Philips N.V
  • Medtronic Plc.
  • Mortara Instrument Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Schiller AG
  • Spacelabs Healthcare Inc.
  • St. Jude Medical Inc.
  • Welch Allyn

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiovascular Disease Monitoring and Diagnostic Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cardiovascular Diseases Spurs Demand for Monitoring Devices
    • Advances in Wearable Heart Monitoring Technologies Propel Market Growth
    • Integration of AI in Cardiovascular Diagnostics Strengthens Diagnostic Accuracy
    • Telemedicine and Remote Monitoring Trends Expand Addressable Market Opportunity
    • Aging Populations Worldwide Bolster Demand for Cardiovascular Monitoring
    • Miniaturization and Technological Advancements in Device Manufacture Enhance Usability
    • Mobile Health Applications' Influence on Consumer Health Management
    • Advances in Echocardiography Technology Create New Diagnostic Opportunities
    • Increasing Demand for Non-invasive Diagnostic Methods
    • Continuous Monitoring Technologies Set the Stage for Improved Patient Outcomes
    • Growth in Heart Failure Incidences Drives Needs for Advanced Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for ECG Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for ECG Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for ECG Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Holter Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Holter Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Holter Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiovascular Disease Monitoring and Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Cardiovascular Disease Monitoring and Diagnostic Devices by Segment - Percentage Breakdown of Value Sales for ECG Systems, Holter Monitors, Implantable Loop Recorders and Other Segments for the Years 2014, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦